Appendix 3B - Proposed issue of securitiesAppendix 3B - Proposed issue of securities1 / 5Announcement SummaryEntity namePERCHERON THERAPEUTICS LIMITEDAnnouncement TypeNew announcementDate of this announcement5/10/2026The Proposed issue is:Total number of +securities proposed to be issued for a...
Proposed issue of securities - PER
Filed with ASX ·
6ix hasn’t read this filing yet.
Percheron Therapeutics Limited on 6ix
Earlier from Percheron Therapeutics
- Final Director's Interest Notice
- Initial Director's Interest Notice
- Dr Michael Baker Commences as CEO and MD
- Notice under S708A
- Application for quotation of securities - PER
Later from Percheron Therapeutics
- Annual General Meeting - Chair Address
- Annual General Meeting - Management Presentation
- Results of Annual General Meeting
- Notification regarding unquoted securities - PER
- Change of Director's Interest Notice
Follow Percheron Therapeutics into a list and get an email when it puts out news.
Follow Percheron Therapeutics